The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts for therapeutic applications.

Avance Biosciences is proud to announce the launch of its Next-Generation Sequencing (NGS) Center of Excellence, a purpose-built facility designed to unify and enhance the company's sequencing ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Q1 results, resolving litigation, but faces trade and NIH policy challenges. Click for my look at TXG stock prospects.

10x Genomics, Inc. (NASDAQ: TXG) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It has announced a ...

Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales ...

Prospective parents using IVF will soon be able to rank embryos using genetic and other information in the hopes of extending the longevity of their offspring, according to the 25-year-old ...